The White House used a Washington Post headline on Saturday to argue President Donald Trump drove a 3.1% July drop in prescription drug prices, the steepest year-over-year decline in more than six decades, after Consumer Price Index data showed the fall. Experts cited in the article said the move more likely stems from Medicare drug-price negotiations mandated by Joe Biden's 2022 Inflation Reduction Act than from Trump administration actions.